Preventing Essential Medical Device Shortages Act of 2020

Hozzl · 2022-03-02T16:13:00Z

Explore the details of Senate Bill 3468 Preventing Essential Medical Device Shortages Act of 2020 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/2/2022, 4:13 PM

Congressional Summary of S 3468

Preventing Essential Medical Device Shortages Act of 2020

This bill requires manufacturers to notify the Food and Drug Administration (FDA) of potential disruptions to the supply of essential medical devices. Specifically, a manufacturer of an essential medical device must notify the FDA of a permanent discontinuance or temporary interruption that is likely to lead to a meaningful disruption in the supply of the device in the United States.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3468

Bill S 3468 is currently in the status of Bill Introduced since March 12, 2020. Bill S 3468 was introduced during Congress 116 and was introduced to the Senate on March 12, 2020. Bill S 3468's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 12, 2020

Bipartisan Support of Bill S 3468

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3468

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Congressional oversight

- Department of Health and Human Services

- Drug safety, medical device, and laboratory regulation

- Emergency medical services and trauma care

- Government information and archives

- Government studies and investigations

- Health technology, devices, supplies

- Manufacturing

Alternate Title(s) of Bill S 3468

Preventing Essential Medical Device Shortages Act of 2020

A bill to require the manufacturers of certain essential medical devices to notify the Food and Drug Administration when such manufacturers become aware of a circumstance that could lead to a shortage of such devices, and for other purposes.